Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

REVBREVELATION BIOSCIENCES, INC.

Nasdaq · CIK 0001810560
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts235

Identity from submissions API

NameREVELATION BIOSCIENCES, INC.
CIK0001810560
TickersREVB, REVBW
ExchangesNasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN843898466
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-800-3717
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Petra Acquisition Inc. (2020-05-14T00:00:00.000Z → 2022-01-11T00:00:00.000Z)
Business address
4660 LAJOLLA VILLAGE DRIVE
SUITE 100
SAN DIEGO
CA
92122
CA
Mailing address
4660 LAJOLLA VILLAGE DRIVE
SUITE 100
SAN DIEGO
CA
92122
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

390 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 8-K 8-K 7.01,9.01 0001193125-26-460055 001-39603 261550918 34 219317 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001193125-26-450210 001-39603 261528664 34 514686 1 1
2026-11-05 10-Q 10-Q 0001193125-26-450194 001-39603 261528621 34 9239038 1 1
2026-08-19 8-K 8-K 5.02,9.01 0001193125-26-357120 001-39603 261296284 34 335358 1 1
2026-08-18 4 4 0001193125-26-355663 5343
2026-08-18 4 4 0001193125-26-355662 5239
2026-08-18 4 4 0001193125-26-355661 9382
2026-08-18 4 4 0001193125-26-355659 5262
2026-08-18 4 4 0001193125-26-355658 5274
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003611 005-91762 261277286 34 10742
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-338097 001-39603 261249428 34 505387 1 1
2026-08-06 10-Q 10-Q 0001193125-26-337967 001-39603 261248958 34 8624868 1 1
2026-07-13 8-A12B 8-A12B 0001193125-26-302077 001-39603 261171693 34 40455
2026-07-13 8-K 8-K 1.01,3.03,5.03,7.01,9.01 0001193125-26-302008 001-39603 261171386 34 928886 1 1
2026-06-24 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-26-281200 001-39603 261116544 34 829306 1 1
2026-06-01 8-K 8-K 8.01,9.01 0001193125-26-251784 001-39603 261052432 34 6805706 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002179 005-91762 26984332 34 10546
2026-05-11 DEF 14A DEF 14A 0001193125-26-215804 001-39603 26961268 34 2158810
2026-05-11 ARS ARS 0001193125-26-215826 001-39603 26961046 34 9514633
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-212064 001-39603 26953875 34 388023 1 1
2026-05-07 10-Q 10-Q 0001193125-26-211871 001-39603 26953147 34 7453369 1 1
2026-05-01 4 4 0001193125-26-201769 5609
2026-05-01 4 4 0001193125-26-201764 6833
2026-04-30 PRE 14A PRE 14A 0001193125-26-196729 001-39603 26926163 34 1349053
2026-04-15 S-8 S-8 0001193125-26-157022 333-295070 26864286 33 721264 1 1
2026-03-19 8-K 8-K 3.03,5.07,9.01 0001193125-26-116012 001-39603 26774485 34 207767 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-076833 001-39603 26688937 34 443065 1 1
2026-02-26 10-K 10-K 0001193125-26-076552 001-39603 26687845 34 42935056 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001224 005-91762 26645048 34 10767
2026-02-17 DEF 14A DEF 14A 0001193125-26-053984 001-39603 26638837 34 1299591
2026-02-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000530 333-293078 26623094 33 1878
2026-02-11 424B3 424B3 0001193125-26-046891 333-293078 26622207 33 177574
2026-02-09 CORRESP filename1.htm 0001193125-26-042685 17992
2026-02-06 PRE 14A PRE 14A 0001193125-26-041273 001-39603 26608183 34 255089
2026-02-06 UPLOAD filename1.pdf 0000000000-26-001281 333-293078 40217
2026-02-05 4 4 0001193125-26-039700 5584
2026-02-05 4 4 0001193125-26-039695 5561
2026-02-05 4 4 0001193125-26-039693 5596
2026-02-05 4 4 0001193125-26-039690 5676
2026-02-05 4 4 0001193125-26-039686 6947
2026-01-30 S-3 S-3 0001193125-26-031760 333-293078 26583348 33 522579 1 1
2026-01-29 8-K 8-K 1.01,3.02,3.03,9.01 0001193125-26-027742 001-39603 26574027 34 610096 1 1
2026-01-22 8-K 8-K 8.01,9.01 0001193125-26-018332 001-39603 26549344 34 18843585 1 1
2026-01-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001535610-26-000013 005-91762 26544526 34 9378
2026-01-12 4 4 0001193125-26-010648 5315
2026-01-12 4 4 0001193125-26-010642 6701
2026-01-12 4 4 0001193125-26-010625 5243
2026-01-12 4 4 0001193125-26-010613 5231
2026-01-12 4 4 0001193125-26-010586 5208
2025-12-03 8-K 8-K 3.03,5.07,8.01,9.01 0001193125-25-306915 001-39603 251547244 34 220047 1 1
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005142 005-91762 251488611 34 10572
2025-11-12 S-8 S-8 0001193125-25-277581 333-291467 251472791 33 380560 1 1
2025-11-10 DEF 14A DEF 14A 0001193125-25-273712 001-39603 251465781 34 1790924
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-269696 001-39603 251458854 34 428259 1 1
2025-11-06 10-Q 10-Q 0001193125-25-269450 001-39603 251458112 34 7734701 1 1
2025-10-31 4 4 0001193125-25-260426 5185
2025-10-31 4 4 0001193125-25-260423 5311
2025-10-31 4 4 0001193125-25-260419 5220
2025-10-31 4 4 0001193125-25-260417 6700
2025-10-31 4 4 0001193125-25-260415 5207
2025-10-30 PRE 14A PRE 14A 0001193125-25-258785 001-39603 251438284 34 245867
2025-10-29 8-K 8-K 7.01,9.01 0001193125-25-256367 001-39603 251430257 34 236364 1 1
2025-10-15 8-K 8-K 7.01,9.01 0001193125-25-240400 001-39603 251395595 34 241574 1 1
2025-09-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003237 333-290309 251362418 33 1879
2025-09-30 424B3 424B3 0001193125-25-225254 333-290309 251361475 33 175340
2025-09-30 S-3/A S-3/A 0001193125-25-223617 333-290309 251357735 33 525009 1 1
2025-09-29 CORRESP filename1.htm 0001193125-25-223620 17431
2025-09-29 CORRESP filename1.htm 0001193125-25-223618 21556
2025-09-24 UPLOAD filename1.pdf 0000000000-25-010384 333-290309 43367
2025-09-22 DEF 14A DEF 14A 0001193125-25-211333 001-39603 251330209 34 1783257
2025-09-16 S-3 S-3 0001193125-25-205145 333-290309 251318119 33 595906 1 1
2025-09-15 8-K 8-K 1.01,3.02,3.03,8.01,9.01 0001193125-25-203750 001-39603 251314982 34 663158 1 1
2025-09-12 PRE 14A PRE 14A 0000950170-25-114524 001-39603 251311557 34 244503
2025-09-09 8-K 8-K 8.01,9.01 0001810560-25-000006 001-39603 251301706 34 4295278 1 1
2025-08-08 8-K 8-K 2.02,9.01 0000950170-25-105485 001-39603 251196268 34 428225 1 1
2025-08-08 10-Q 10-Q 0000950170-25-105284 001-39603 251195638 34 7136663 1 1
2025-07-09 8-K 8-K 3.03,5.03,8.01,9.01 0000950170-25-094789 001-39603 251113795 34 278262 1 1
2025-06-25 8-K 8-K 5.07,8.01 0000950170-25-089972 001-39603 251073934 34 1620266 1 1
2025-06-09 DEF 14A DEF 14A 0000950170-25-083815 001-39603 251034816 34 2987538
2025-06-04 8-K 8-K 1.01,3.03,8.01,9.01 0000950170-25-081604 001-39603 251023124 34 1586260 1 1
2025-05-29 PRE 14A PRE 14A 0000950170-25-078948 001-39603 251003379 34 2397319
2025-05-29 424B3 424B3 0000950170-25-078627 333-287423 25998274 33 5660054
2025-05-28 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001762 333-287423 25997516 33 1878
2025-05-28 8-K 8-K 5.02,8.01 0000950170-25-078340 001-39603 25995565 34 249105 1 1
2025-05-23 CORRESP filename1.htm 0001213900-25-047306 4511
2025-05-23 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-047104 333-287423 25979639 33 12201477 1 1
2025-05-22 CORRESP filename1.htm 0001213900-25-046844 9462
2025-05-22 CORRESP filename1.htm 0001213900-25-046811 8026
2025-05-21 UPLOAD filename1.pdf 0000000000-25-005435 377-07859 45730
2025-05-20 CORRESP filename1.htm 0001213900-25-046001 6034
2025-05-20 S-1 REGISTRATION STATEMENT 0001213900-25-045828 333-287423 25967915 33 12795358 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-067043 001-39603 25926575 34 376154 1 1
2025-05-08 10-Q 10-Q 0000950170-25-066897 001-39603 25925831 34 5999149 1 1
2025-04-09 UPLOAD filename1.pdf 0000000000-25-003798 377-07859 40452
2025-04-04 DRS filename1.htm 0001213900-25-029022 377-07859 25814990 33 11954208
2025-03-17 8-K 8-K 8.01 0000950170-25-040294 001-39603 25744682 34 4502934 1 1
2025-03-06 8-K 8-K 2.02,9.01 0000950170-25-034689 001-39603 25715532 34 425037 1 1
2025-03-06 10-K 10-K 0000950170-25-034584 001-39603 25715152 34 16353379 1 1
2025-02-24 8-K 8-K 8.01,9.01 0000950170-25-025626 001-39603 25657113 34 251969 1 1
2025-02-13 4 4 0000950170-25-020126 4619
2025-02-13 4 4 0000950170-25-020120 5218
2025-02-13 4 4 0000950170-25-020113 5206
2025-02-13 4 4 0000950170-25-020109 5290
2025-02-13 4 4 0000950170-25-020104 6678
2025-02-13 4 4 0000950170-25-020097 5576
2025-02-11 8-K 8-K 8.01,9.01 0000950170-25-017882 001-39603 25609758 34 8473783 1 1
2025-01-30 8-K 8-K 3.03,5.03,9.01 0000950170-25-011197 001-39603 25574922 34 230956 1 1
2025-01-21 8-K 8-K 5.07,8.01,9.01 0000950170-25-007303 001-39603 25542888 34 291473 1 1
2025-01-13 DEFA14A DEFA14A 0000950170-25-004619 001-39603 25525100 34 64236
2025-01-07 8-K 8-K 3.01,8.01,9.01 0000950170-25-002828 001-39603 25514885 34 249768 1 1
2025-01-02 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001535610-25-000003 005-91762 25503583 34 9473
2024-12-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-24-003896 333-283764 241569555 33 1886
2024-12-20 424B3 424B3 0000950170-24-139141 333-283764 241568982 33 173394
2024-12-20 CORRESP filename1.htm 0000950170-24-138951 14925
2024-12-19 CORRESP filename1.htm 0000950170-24-138580 14925
2024-12-19 S-3/A S-3/A 0000950170-24-138462 333-283764 241563463 33 280402
2024-12-18 UPLOAD filename1.pdf 0000000000-24-014000 333-283764 40216
2024-12-16 DEF 14A DEF 14A 0000950170-24-136402 001-39603 241550236 34 1410668
2024-12-12 8-K 8-K 8.01,9.01 0000950170-24-135895 001-39603 241546008 34 205732 1 1
2024-12-12 S-3 S-3 0000950170-24-135845 333-283764 241545440 33 360050
2024-12-06 8-K 8-K 1.01,3.02,3.03,8.01,9.01 0000950170-24-134064 001-39603 241532231 34 865658 1 1
2024-12-05 PRE 14A PRE 14A 0000950170-24-133661 001-39603 241529072 34 924923
2024-11-08 8-K 8-K 2.02,9.01 0000950170-24-124141 001-39603 241440984 34 394968 1 1
2024-11-08 10-Q 10-Q 0000950170-24-124036 001-39603 241440349 34 7075326 1 1
2024-10-21 8-K 8-K 3.01,9.01 0000950170-24-115955 001-39603 241383703 34 204456 1 1
2024-09-27 8-K 8-K 8.01,9.01 0000950170-24-109998 001-39603 241334938 34 338977 1 1
2024-09-25 UPLOAD filename1.pdf 0000000000-24-010883 001-39603 39868
2024-09-23 10-Q/A 10-Q/A 0000950170-24-108797 001-39603 241316765 34 6266414 1 1
2024-09-23 10-Q/A 10-Q/A 0000950170-24-108796 001-39603 241316759 34 5962755 1 1
2024-09-23 10-K/A 10-K/A 0000950170-24-108793 001-39603 241316752 34 7319993 1 1
2024-09-23 CORRESP filename1.htm 0000950170-24-108790 20604
2024-09-13 424B3 424B3 0000950170-24-106340 333-281909 241297672 33 160066
2024-09-13 UPLOAD filename1.pdf 0000000000-24-010381 001-39603 42857
2024-09-12 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-09-12 17:00:00 9999999995-24-002824 333-281909 241296365 33 1886
2024-09-10 CORRESP filename1.htm 0000950170-24-105112 13844
2024-09-09 UPLOAD filename1.pdf 0000000000-24-010175 333-281909 40191
2024-09-03 S-3 S-3 0000950170-24-102912 333-281909 241274950 33 329813
2024-08-26 8-K 8-K 1.01,3.02,3.03,8.01,9.01 0000950170-24-100550 001-39603 241241701 34 620249 1 1
2024-08-19 8-K 8-K 3.01 0000950170-24-098505 001-39603 241220421 34 201669 1 1
2024-08-09 8-K 8-K 2.02,9.01 0000950170-24-094788 001-39603 241193150 34 394919 1 1
2024-08-09 10-Q 10-Q 0000950170-24-094727 001-39603 241192456 34 6537756 1 1
2024-08-02 8-K 8-K 8.01,9.01 0000950170-24-089966 001-39603 241171101 34 201787 1 1
2024-07-26 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-07-26 17:00:00 9999999995-24-002298 333-280908 241148653 33 1886
2024-07-23 CORRESP filename1.htm 0000950170-24-085713 13776
2024-07-23 UPLOAD filename1.pdf 0000000000-24-008324 333-280908 40196
2024-07-19 S-3 S-3 0000950170-24-084922 333-280908 241127817 33 356322
2024-06-24 8-K 8-K 8.01,9.01 0000950170-24-076761 001-39603 241064681 34 233660 1 1
2024-06-18 S-8 S-8 0000950170-24-075011 333-280313 241052904 33 231826
2024-05-16 8-K 8-K 5.07,9.01 0000950170-24-061061 001-39603 24955432 34 217346 1 1
2024-05-10 8-K 8-K 2.02,9.01 0000950170-24-057927 001-39603 24935801 34 351358 1 1
2024-05-10 10-Q 10-Q 0000950170-24-057787 001-39603 24934719 34 6238485 1 1
2024-04-16 DEF 14A DEF 14A 0000950170-24-044514 001-39603 24845636 34 1597103
2024-04-05 PRE 14A PRE 14A 0000950170-24-042241 001-39603 24826418 34 866790
2024-03-22 8-K 8-K 2.02,9.01 0000950170-24-035376 001-39603 24775555 34 384752 1 1
2024-03-22 10-K 10-K 0000950170-24-035322 001-39603 24775118 34 13263719 1 1
2024-03-12 8-K 8-K 7.01,8.01,9.01 0000950170-24-029611 001-39603 24740082 34 6145324 1 1
2024-02-13 SC 13G/A sch13g.htm 0000929638-24-000577 005-91762 24631328 34 74383
2024-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001884552-24-000001 005-91762 24617888 34 14469
2024-02-08 8-K 8-K 1.01,3.03,8.01,9.01 0000950170-24-012748 001-39603 24608917 34 1435667 1 1
2024-02-02 424B3 PROSPECTUS 0001213900-24-009630 333-276232 24591393 33 11236505
2024-01-31 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-01-31 17:15:00 9999999995-24-000263 333-276232 24584887 33 1885
2024-01-30 8-K 8-K 7.01,9.01 0000950170-24-008972 001-39603 24579582 34 13965956 1 1
2024-01-30 CORRESP filename1.htm 0001213900-24-007960 6522
2024-01-30 S-1/A REGISTRATION STATEMENT 0001213900-24-007885 333-276232 24577877 33 25876871 1 1
2024-01-29 S-1/A REGISTRATION STATEMENT 0001213900-24-007475 333-276232 24575086 33 26485491 1 1
2024-01-29 CORRESP filename1.htm 0001213900-24-007480 6976
2024-01-23 8-K 8-K 3.03,5.03 0000950170-24-006510 001-39603 24552870 34 224036 1 1
2024-01-22 8-K 8-K 5.07,9.01 0000950170-24-006051 001-39603 24548855 34 212136 1 1
2024-01-03 SC 13G REVB 13G 1.03.24 0001535610-24-000018 005-91762 24504439 34 13316
2024-01-02 UPLOAD filename1.pdf 0000000000-24-000028 333-276232 43350
2023-12-22 DEF 14A DEF 14A 0000950170-23-072738 001-39603 231510686 34 2038764
2023-12-22 S-1 REGISTRATION STATEMENT 0001213900-23-098043 333-276232 231508743 33 26663314 1 1
2023-12-12 PRE 14A PRE 14A 0000950170-23-069769 001-39603 231481874 34 229510
2023-12-12 4 FORM 4 SUBMISSION 0001209191-23-058296 5456
2023-11-13 8-K 8-K 2.02,9.01 0000950170-23-063019 001-39603 231399294 34 470322 1 1
2023-11-09 10-Q 10-Q 0000950170-23-062025 001-39603 231392381 34 7890260 1 1
2023-10-18 4 FORM 4 SUBMISSION 0001209191-23-053102 5459
2023-10-17 4 FORM 4 SUBMISSION 0001209191-23-052953 5459
2023-10-12 8-K 8-K 7.01,8.01,9.01 0000950170-23-053115 001-39603 231323000 34 15176947 1 1
2023-10-02 3 FORM 3 SUBMISSION 0001209191-23-051081 6300
2023-10-02 8-K 8-K 5.02,7.01,9.01 0000950170-23-051141 001-39603 231300007 34 275788 1 1
2023-10-02 4 FORM 4 SUBMISSION 0001209191-23-051037 5457
2023-09-28 144 xsl144X01/primary_doc.xml 0001950047-23-004296 001-39603 231291204 33 5493
2023-09-18 4 FORM 4 SUBMISSION 0001209191-23-049786 8504
2023-08-11 8-K 8-K 2.02,9.01 0000950170-23-041889 001-39603 231164579 34 508711 1 1
2023-08-11 S-8 S-8 0000950170-23-041878 333-273933 231164493 33 347594
2023-08-11 10-Q 10-Q 0000950170-23-041851 001-39603 231164140 34 8203033 1 1
2023-08-11 8-K 8-K 3.01 0000950170-23-041840 001-39603 231164014 34 220088 1 1
2023-07-14 8-K 8-K 5.07 0000950170-23-033021 001-39603 231089619 34 245173 1 1
2023-07-07 DEFA14A DEFA14A 0000950170-23-032235 001-39603 231076893 34 72376
2023-07-07 8-K 8-K 5.03,9.01 0000950170-23-032233 001-39603 231076852 34 504578 1 1
2023-06-29 8-K 8-K 7.01,9.01 0000950170-23-030766 001-39603 231057720 34 313323 1 1
2023-06-15 DEFA14A DEFA14A 0000950170-23-028340 001-39603 231018106 34 453631
2023-06-12 8-K 8-K 7.01,9.01 0000950170-23-027498 001-39603 231008365 34 280264 1 1
2023-05-25 8-K 8-K 7.01,9.01 0000950170-23-024262 001-39603 23961280 34 14394420 1 1
2023-05-22 8-K 8-K 2.02,7.01,9.01 0000950170-23-023380 001-39603 23943602 34 447493 1 1
2023-05-22 10-Q 10-Q 0000950170-23-023313 001-39603 23942361 34 7599597 1 1
2023-05-15 NT 10-Q NT 10-Q 0000950170-23-022298 001-39603 23924572 34 73583
2023-05-05 DEF 14A DEF 14A 0000950170-23-018333 001-39603 23894118 34 1225129
2023-04-25 PRE 14A PRE 14A 0000950170-23-014470 001-39603 23845380 34 1216009
2023-04-19 4 FORM 4 SUBMISSION 0001209191-23-024898 7431
2023-04-18 4 FORM 4 SUBMISSION 0001209191-23-024646 5292
2023-04-18 4 FORM 4 SUBMISSION 0001209191-23-024643 5368
2023-04-18 4 FORM 4 SUBMISSION 0001209191-23-024638 5436
2023-04-18 4 FORM 4 SUBMISSION 0001209191-23-024634 5380
2023-04-03 8-K 8-K 2.02,7.01,9.01 0000950170-23-011612 001-39603 23793224 34 489624 1 1
2023-03-30 10-K 10-K 0000950170-23-011000 001-39603 23781400 34 12040039 1 1
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013633 5593
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013629 5566
2023-02-21 SC 13G schedule13g.htm 0000929638-23-000670 005-91762 23648993 34 81559
2023-02-21 SC 13G SCHEDULE 13G 0001213900-23-013027 005-91762 23645086 34 61218
2023-02-17 8-K 8-K 8.01 0000950170-23-003213 001-39603 23642667 34 219412 1 1
2023-02-14 SC 13G SCHEDULE 13G 0001884552-23-000002 005-91762 23625736 34 106141
2023-02-14 5 PRIMARY DOCUMENT 0001884552-23-000001 16399
2023-02-13 8-K 8-K 1.01,3.03,7.01,9.01 0000950170-23-002652 001-39603 23620231 34 1711349 1 1
2023-02-13 424B3 PROSPECTUS 0001213900-23-010412 333-268576 23613683 33 2453239
2023-02-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-02-09 09:30:00 9999999995-23-000351 333-268576 23608381 33 1836
2023-02-09 S-1MEF REGISTRATION STATEMENT 0001213900-23-009573 333-269655 23601651 33 95892
2023-02-09 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-23-009501 333-268576 23600976 33 8631840 1 1
2023-02-06 SC 13G/A paic13ga31dec2022.htm 0001357550-23-000032 005-91762 23589985 34 99923
2023-02-06 CORRESP filename1.htm 0001213900-23-008310 6009
2023-02-01 CORRESP filename1.htm 0001213900-23-006689 5273
2023-02-01 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-23-006688 333-268576 23576807 33 9282721 1 1
2023-01-31 8-K 8-K 3.03,5.03,5.07,7.01,9.01 0000950170-23-001502 001-39603 23573354 34 347800 1 1
2023-01-31 SC 13G/A SC 13G/A 0001193125-23-020224 005-91762 23572327 34 66527
2023-01-13 DEFA14A DEFA14A 0000950170-23-000759 001-39603 23529078 34 93585
2023-01-13 25-NSE xslF25X02/primary_doc.xml 0001354457-23-000024 001-39603 23529013 34 3056
2023-01-10 8-K 8-K 7.01,9.01 0000950170-23-000613 001-39603 23521210 34 14401059 1 1
2023-01-10 8-K 8-K 8.01,9.01 0000950170-23-000608 001-39603 23521134 34 281036 1 1
2022-12-30 DEF 14A DEFINITIVE PROXY STATEMENTS 0001213900-22-084038 001-39603 221502139 34 436078
2022-12-21 8-K 8-K 1.01,3.02,3.03,5.03,9.01 0000950170-22-026866 001-39603 221478582 34 447110 1 1
2022-12-20 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-22-081401 001-39603 221475024 34 436701
2022-12-12 8-K 8-K 3.01 0000950170-22-026382 001-39603 221457137 34 229048 1 1
2022-11-29 S-1 REGISTRATION STATEMENT 0001213900-22-075572 333-268576 221427655 33 10288847 1 1
2022-11-25 8-K CURRENT REPORT 3.01 0001213900-22-075030 001-39603 221417926 34 271562 1 1
2022-11-18 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-11-18 16:00:00 9999999995-22-003347 333-268076 221403365 33 1837
2022-11-17 CORRESP filename1.htm 0001213900-22-073451 5828
2022-11-16 CORRESP filename1.htm 0001213900-22-073148 8185
2022-11-16 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-22-073146 333-268076 221394664 33 10042536 1 1
2022-11-14 UPLOAD filename1.pdf 0000000000-22-012322 44860
2022-11-10 8-K 8-K 2.02,7.01,9.01 0000950170-22-024560 001-39603 221378294 34 507411 1 1
2022-11-10 10-Q 10-Q 0000950170-22-024436 001-39603 221376970 34 8392144 1 1
2022-10-31 S-1 REGISTRATION STATEMENT 0001213900-22-067716 333-268076 221346874 33 10902121 1 1
2022-10-25 8-K 8-K 7.01,9.01 0000950170-22-020014 001-39603 221329514 34 333167 1 1
2022-10-06 8-K 8-K 7.01,9.01 0000950170-22-019354 001-39603 221298164 34 1807073 1 1
2022-08-17 SC 13G/A AMENDMENT TO FORM SC 13G 0001683168-22-005877 005-91762 221174893 34 53398
2022-08-17 8-K 8-K 2.02,7.01,9.01 0000950170-22-017552 001-39603 221174567 34 492660 1 1
2022-08-15 10-Q 10-Q 0000950170-22-017405 001-39603 221166498 34 7163603 1 1
2022-08-01 8-K 8-K 1.01,8.01,9.01 0000950170-22-013698 001-39603 221125681 34 1197291 1 1
2022-07-27 424B3 PROSPECTUS 0001213900-22-042058 333-266108 221111588 33 1726070
2022-07-25 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-07-25 17:00:00 9999999995-22-002156 333-266108 221104780 33 1837
2022-07-25 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-22-041331 333-266108 221103875 33 7398130 1 1
2022-07-25 CORRESP filename1.htm 0001213900-22-041170 4864
2022-07-21 S-1/A AMENDMENT NO. 2 TO FORM S-1 0001213900-22-040761 333-266108 221097903 33 7547084 1 1
2022-07-18 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-22-040064 333-266108 221089914 33 268473 1 1
2022-07-18 UPLOAD filename1.pdf 0000000000-22-007547 40341
2022-07-13 S-1 REGISTRATION STATEMENT 0001213900-22-038955 333-266108 221080033 33 8240157 1 1
2022-06-27 424B3 PROSPECTUS 0001213900-22-035162 333-265326 221044284 33 1775806
2022-06-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-06-10 16:00:00 9999999995-22-001764 333-265326 221010601 33 1837
2022-06-10 8-K 8-K 3.01 0000950170-22-011469 001-39603 221008768 34 224512 1 1
2022-06-07 CORRESP filename1.htm 0001213900-22-031550 4846
2022-06-06 UPLOAD filename1.pdf 0000000000-22-006093 40319
2022-05-31 S-8 REGISTRATION STATEMENT 0001213900-22-030471 333-265329 22984783 33 113389
2022-05-31 S-1 REGISTRATION STATEMENT 0001213900-22-030462 333-265326 22984700 33 7668394 1 1
2022-05-31 8-K 8-K 3.01 0000950170-22-010946 001-39603 22984106 34 223953 1 1
2022-05-17 8-K 8-K 2.02,9.01 0000950170-22-010146 001-39603 22931559 34 455013 1 1
2022-05-16 10-Q 10-Q 0000950170-22-009906 001-39603 22924910 34 6588996 1 1
2022-05-06 8-K CURRENT REPORT 4.01,9.01 0001213900-22-024526 001-39603 22901028 34 270750 1 1
2022-04-22 8-K/A AMENDMENT NO. 2 TO FORM 8-K 9.01 0001213900-22-021206 001-39603 22846732 34 620857 1 1
2022-04-15 8-K/A AMENDMENT NO. 1 TO FORM 8-K 9.01 0001213900-22-020216 001-39603 22830698 34 633135 1 1
2022-04-15 10-K ANNUAL REPORT 0001213900-22-020179 001-39603 22830464 34 5276820 1 1
2022-03-31 NT 10-K NOTIFICATION OF LATE FILING 0001213900-22-016797 001-39603 22792872 34 27314
2022-03-24 SC 13G SC 13G 0001683168-22-001902 005-91762 22764875 34 52867
2022-03-15 8-K CURRENT REPORT 7.01,9.01 0001213900-22-012515 001-39603 22740672 34 6218246 1 1
2022-03-10 SC 13G/A KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#2) 0001072613-22-000345 005-91762 22729029 34 79644
2022-02-28 4 FORM 4 SUBMISSION 0001209191-22-013741 5428
2022-02-15 SC 13D SCHEDULE 13D 0001213900-22-007741 005-91762 22636576 34 107206
2022-02-14 SC 13G/A paic20211231.htm 0001076809-22-000110 005-91762 22633793 34 65362
2022-02-14 SC 13G/A KARPUS INVESTMENT MGT / REVELATION BIOSCIENCES - SCHEDULE 13G/A(#1) 0001072613-22-000268 005-91762 22632707 34 79671
2022-02-11 SC 13G/A FORM SC 13G/A 0001062993-22-003699 005-91762 22619019 34 32484
2022-02-11 8-K CURRENT REPORT 7.01,9.01 0001213900-22-006506 001-39603 22615597 34 2503554 1 1
2022-02-10 4 FORM 4 SUBMISSION 0001209191-22-008580 7404
2022-02-10 424B3 PROSPECTUS 0001213900-22-006369 333-262410 22613202 33 12066372
2022-02-09 4/A FORM 4/A SUBMISSION 0001209191-22-008025 8865
2022-02-09 SC 13G paic13g31dec2021.htm 0001357550-22-000067 005-91762 22606540 34 104679
2022-02-08 4 FORM 4 SUBMISSION 0001209191-22-007837 7563
2022-02-07 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-02-07 16:00:00 9999999995-22-000357 333-262410 22599166 33 1836
2022-02-04 SC 13G/A PAIC 13G/A 0001393825-22-000073 005-91762 22592826 34 56065
2022-02-03 CORRESP filename1.htm 0001213900-22-005227 5781
2022-02-03 CORRESP filename1.htm 0001213900-22-005199 5879
2022-02-02 UPLOAD filename1.pdf 0000000000-22-001360 40358
2022-01-28 CORRESP filename1.htm 0001213900-22-004280 11044
2022-01-28 S-1 REGISTRATION STATEMENT 0001213900-22-004272 333-262410 22569862 33 21950738 1 1
2022-01-27 8-K CURRENT REPORT 1.01,3.02,7.01,9.01 0001213900-22-003972 001-39603 22563178 34 1090866 1 1
2022-01-20 3 FORM 3 SUBMISSION 0001209191-22-004162 11642
2022-01-20 3 FORM 3 SUBMISSION 0001209191-22-004160 10423
2022-01-20 3 FORM 3 SUBMISSION 0001209191-22-004159 8925
2022-01-20 3 FORM 3 SUBMISSION 0001209191-22-004157 10442
2022-01-20 3 FORM 3 SUBMISSION 0001209191-22-004153 7854
2022-01-20 3 FORM 3 SUBMISSION 0001209191-22-004145 9568
2022-01-20 SC 13G SC 13G 0001193125-22-012695 005-91762 22540149 34 95756
2022-01-14 8-K CURRENT REPORT 2.01,3.02,5.01,5.02,5.03,5.06,9.01 0001213900-22-002152 001-39603 22532166 34 507541 1 1
2022-01-13 8-K CURRENT REPORT 7.01,9.01 0001213900-22-001924 001-39603 22529021 34 6007801 1 1
2022-01-12 8-K CURRENT REPORT 5.03,5.07,9.01 0001213900-22-001766 001-39603 22527047 34 298189 1 1
2022-01-11 4 FORM 4 FILING 0001376474-22-000016 6424
2022-01-11 SC 13G/A SCHEDULE 13G/A 0001376474-22-000008 005-91762 22523784 34 42981
2021-12-23 8-K CURRENT REPORT 1.01,2.03,7.01,8.01,9.01 0001213900-21-067371 001-39603 211518204 34 638623 1 1
2021-12-17 DEFA14A CURRENT REPORT 0001213900-21-065972 001-39603 211501257 34 35459
2021-12-17 8-K CURRENT REPORT 8.01 0001213900-21-065969 001-39603 211501251 34 276416 1 1
2021-12-16 424B3 PROSPECTUS 0001213900-21-065679 333-259638 211497828 33 17763781
2021-12-14 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2021-12-14 16:00:00 9999999995-21-004678 333-259638 211492838 33 1662
2021-12-14 CORRESP filename1.htm 0001213900-21-065171 6963
2021-12-13 S-4/A REGISTRATION STATEMENT 0001213900-21-064987 333-259638 211488381 33 28280200 1 1
2021-12-07 S-4/A REGISTRATION STATEMENT 0001213900-21-063766 333-259638 211474575 33 28586777 1 1
2021-12-06 CORRESP filename1.htm 0001213900-21-063767 58509
2021-11-26 UPLOAD filename1.pdf 0000000000-21-014295 60434
2021-11-24 DEFA14A CURRENT REPORT 0001213900-21-062020 001-39603 211448107 34 35466
2021-11-24 8-K CURRENT REPORT 8.01 0001213900-21-062013 001-39603 211448045 34 272871 1 1
2021-11-04 CORRESP filename1.htm 0001213900-21-056626 100636
2021-11-04 S-4/A REGISTRATION STATEENT 0001213900-21-056625 333-259638 211378652 33 29044799 1 1
2021-11-02 3 FORM 3 FILING 0001376474-21-000382 5652
2021-11-01 425 FORM 425 0001213900-21-055680 001-39603 211365724 34 33593
2021-10-29 10-Q QUARTERLY REPORT 0001213900-21-055498 001-39603 211364066 34 2879513 1 1
2021-10-25 UPLOAD filename1.pdf 0000000000-21-012939 74457
2021-10-25 425 425 0001213900-21-054470 001-39603 211344832 34 34987
2021-10-19 8-K CURRENT REPORT 1.01,2.03,8.01,9.01 0001213900-21-053548 001-39603 211331990 34 414097 1 1
2021-10-13 8-K CURRENT REPORT 5.03,5.07,7.01,9.01 0001213900-21-052510 001-39603 211319879 34 308914 1 1
2021-10-12 SC 13G/A paicu20210930.htm 0001076809-21-000224 005-91762 211318618 34 65136
2021-10-12 SC 13G/A SCHEDULE 13G/A 0001376474-21-000347 005-91762 211317547 34 42864
2021-10-04 425 FORM 425 0001213900-21-051277 001-39603 211301226 34 41648
2021-09-28 425 FORM 425 0001213900-21-050351 001-39603 211287900 34 30710
2021-09-28 SC 13G SCHEDULE 13G 0001376474-21-000318 005-91762 211285192 34 42853
2021-09-24 DEFR14A DEFINITIVE PROXY STATEMENT 0001213900-21-049632 001-39603 211273547 34 449542
2021-09-23 8-K CURRENT REPORT 1.01,2.03,5.03,8.01,9.01 0001213900-21-049595 001-39603 211273288 34 564524 1 1
2021-09-23 4 OWNERSHIP DOCUMENT 0001076809-21-000221 9765
2021-09-21 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-21-048974 001-39603 211264658 34 448321
2021-09-20 S-4 REGISTRATION STATEMENT 0001213900-21-048712 333-259638 211261944 33 18252072
2021-09-07 PRE 14A PRELIMINARY PROXY STATEMENT 0001213900-21-046750 001-39603 211238114 34 225959
2021-09-02 425 CURRENT REPORT 0001213900-21-046429 001-39603 211234127 34 1380738
2021-09-02 8-K CURRENT REPORT 1.01,9.01 0001213900-21-046426 001-39603 211234109 34 1868928 1 1
2021-08-31 DEFA14A CURRENT REPORT 0001213900-21-045755 001-39603 211225450 34 6628005
2021-08-31 8-K CURRENT REPORT 7.01,9.01 0001213900-21-045753 001-39603 211225437 34 6916123 1 1
2021-08-23 10-Q FORM 10-Q 0001213900-21-044217 001-39603 211195615 34 2547946 1 1
2021-08-17 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-21-043237 001-39603 211180815 34 26362
2021-08-10 SC 13G KARPUS INVESTMENT MGT / PETRA ACQUISITION - SCHEDULE 13G 0001072613-21-000510 005-91762 211159835 34 79013
2021-06-22 10-Q QUARTERLY REPORT 0001213900-21-033574 001-39603 211035984 34 1784135 1
2021-06-16 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-21-032736 001-39603 211022011 34 3036326 1
2021-06-16 8-K CURRENT REPORT 4.02 0001213900-21-032735 001-39603 211021999 34 20657
2021-06-01 8-K CURRENT REPORT 3.01,8.01,9.01 0001213900-21-030290 001-39603 21985753 34 28784
2021-05-18 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-21-027317 001-39603 21933329 34 23370
2021-03-31 10-K ANNUAL REPORT 0001213900-21-019097 001-39603 21792433 34 2390083 1
2021-03-11 3 PRIMARY DOCUMENT 0001850363-21-000001 3680
2021-03-05 8-K/A AMENDMENT TO FORM 8-K 5.02 0001213900-21-013773 001-39603 21719229 34 23673
2021-02-23 8-K CURRENT REPORT 5.02 0001213900-21-011105 001-39603 21665286 34 23280
2021-02-16 SC 13G/A paicu20201231.htm 0001076809-21-000103 005-91762 21630685 34 64855
2021-02-10 SC 13G PAIC 13G 0001393825-21-000057 005-91762 21613373 34 58216
2021-02-10 SC 13G FORM SC 13G 0001062993-21-001141 005-91762 21609456 34 33526
2021-02-08 SC 13G/A SC 13G/A 0001193125-21-031674 005-91762 21598682 34 77155
2021-02-05 SC 13G/A formsc13ga.htm 0001493152-21-002751 005-91762 21595341 34 120804
2020-12-31 4 xslF345X03/ownership.xml 0001213900-20-045622 5108
2020-12-31 4 xslF345X03/ownership.xml 0001213900-20-045618 5115
2020-11-16 10-Q QUARTERLY REPORT 0001213900-20-037337 001-39603 201316656 34 1478937 1
2020-11-12 4 PRIMARY DOCUMENT 0001076809-20-000236 6396
2020-11-10 SC 13G paic.htm 0001076809-20-000230 005-91762 201301463 34 59501
2020-11-10 8-K FORM 8-K 8.01,9.01 0001213900-20-036166 001-39603 201301118 34 24548
2020-10-21 4 xslF345X03/ownership.xml 0001213900-20-032604 6461
2020-10-21 3 OWNERSHIP DOCUMENT 0001213900-20-032600 6847
2020-10-20 4 xslF345X03/ownership.xml 0001213900-20-032284 6453
2020-10-19 8-K CURRENT REPORT 1.01,9.01 0001213900-20-032103 001-39603 201246906 34 117636
2020-10-19 4 PRIMARY DOCUMENT 0001076809-20-000191 8020
2020-10-19 3 PRIMARY DOCUMENT 0001076809-20-000190 5491
2020-10-16 SC 13G formsc13g.htm 0001493152-20-019545 005-91762 201243456 34 124901
2020-10-16 SC 13G SC 13G 0001193125-20-270779 005-91762 201243132 34 83958
2020-10-13 8-K CURRENT REPORT 1.01,3.02,5.03,8.01,9.01 0001213900-20-031128 001-39603 201237390 34 777953
2020-10-13 3 xslF345X02/ownership.xml 0001213900-20-030998 6808
2020-10-13 424B4 PROSPECTUS 0001213900-20-030918 333-240175 201234326 33 2133227
2020-10-09 3 xslF345X02/ownership.xml 0001213900-20-030900 3460
2020-10-09 3 xslF345X02/ownership.xml 0001213900-20-030898 3381
2020-10-09 3 xslF345X02/ownership.xml 0001213900-20-030896 3379
2020-10-09 3 OWNERSHIP DOCUMENT 0001213900-20-030894 3411
2020-10-09 3 OWNERSHHIP DOCUMENT 0001213900-20-030891 3408
2020-10-09 CERT 8A_Cert_PAIC.pdf 0001354457-20-000575 001-39603 201232428 34 86373
2020-10-07 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-10-07 16:00:00 9999999995-20-002769 333-240175 201230032 33 1647
2020-10-07 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-20-030446 001-39603 201228852 34 39325
2020-09-21 S-1/A REGISTRATION STATEMENT 0001213900-20-027538 333-240175 201186383 33 2825021
2020-08-26 S-1/A AMENDMENT NO. 3 TO FROM S-1 0001213900-20-023736 333-240175 201134079 33 3185594
2020-08-19 S-1/A REGISTRATION STATEMENT 0001213900-20-022817 333-240175 201116484 33 3030303
2020-08-11 S-1/A REGISTRATION STATEMENT 0001213900-20-021399 333-240175 201092419 33 2792660
2020-07-29 S-1 fs12020_petraacquisition.htm 0001213900-20-019100 333-240175 201058091 33 3070396
2020-05-14 DRS filename1.htm 0001213900-20-012048 377-03171 20874448 33 2321360

Latest XBRL company facts

One latest value per concept from companyfacts (235 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 683,442 2026-11-02 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
dei EntityPublicFloat Entity Public Float USD 3.42M 2025-06-30 2025 FY 10-K 2026-02-26 0001193125-26-076552
ffd NetFeeAmt NetFeeAmt USD 126.95 2026-04-14 S-8 2026-04-15 0001193125-26-157022
ffd TtlFeeAmt TtlFeeAmt USD 126.95 2026-04-14 S-8 2026-04-15 0001193125-26-157022
ffd TtlOfferingAmt TtlOfferingAmt USD 919,275 2026-04-14 S-8 2026-04-15 0001193125-26-157022
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-14 S-8 2026-04-15 0001193125-26-157022
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 2.32M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 2.32M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 916,160 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 916,160 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 700,000 2022-06-30 2022 FY 10-K 2023-03-30 0000950170-23-011000
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 28,500 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 122,689 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 66.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 482,229 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.33M 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap AdvancesToAffiliate Advances to Affiliate USD 150,000 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap Assets Assets USD 10.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AssetsCurrent Assets, Current USD 9.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 48.30M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 48.30M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare Auction Market Preferred Securities, Stock Series, Par Value Per Share USD/shares 9.5 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap BusinessCombinationConsiderationTransferredOther1 Business Combination, Consideration Transferred, Other USD 2.80M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019097
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 57,974 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap Cash Cash USD 537,000 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 9.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -11,734 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001213900-21-055498
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 9.12M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 83,446 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 1.27M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CommonStockConvertibleConversionPriceIncrease Common Stock, Convertible, Conversion Price, Increase USD/shares 10.203 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CommonStockSharesHeldInEmployeeTrustShares Common Stock, Shares Held in Employee Trust, Shares shares 721,995 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 683,442 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 683,442 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CommonStockValue Common Stock, Value, Issued USD 683 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 0 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019097
us-gaap CommonUnitIssued Common Unit, Issued shares 12.94M 2022-01-10 2022 Q3 10-Q 2022-11-10 0000950170-22-024436
us-gaap CommonUnitOutstanding Common Unit, Outstanding shares 369,836 2022-01-10 2022 FY 10-K 2023-03-30 0000950170-23-011000
us-gaap ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear Contractual Obligation, to be Paid, Remainder of Fiscal Year USD 297,714 2022-06-30 2022 Q2 10-Q 2022-08-15 0000950170-22-017405
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 10,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 3 2025-07-07 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 1 2025-07-07 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap CostDirectLabor Cost, Direct Labor USD 1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap CreditRiskDerivativeLiabilitiesAtFairValue Credit Risk Derivative Liabilities, at Fair Value USD 1.01M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 10,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 750,000 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DebtInstrumentConvertibleLiquidationPreferencePerShare DebtInstrumentConvertibleLiquidationPreferencePerShare USD/shares 10.2 2021-10-13 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DebtInstrumentConvertibleThresholdTradingDays Debt Instrument, Convertible, Threshold Trading Days pure 20 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001213900-21-055498
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.40M 2020-12-31 2020 FY 10-K 2021-03-31 0001213900-21-019097
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 24,345 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DebtInstrumentInterestRateDuringPeriod Debt Instrument, Interest Rate During Period pure 0.02 2021-10-01 2021-10-13 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.02 2021-10-13 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 150,000 2020-01-01 2020-06-04 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034584
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.91M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 17.56M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.03M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 821,000 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 14.38M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 451,237 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 780,109 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 17.56M 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap Depreciation Depreciation USD 23,701 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap DerivativeLiabilities Derivative Liability USD 1.01M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 2.39M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap DividendsCommonStockCash Dividends, Common Stock, Cash USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -29.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.47 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009906
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -29.37 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.215 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.029 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011000
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.026 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities USD 795,979 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.14 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap EscrowDeposit Escrow Deposit USD 7.65M 2021-12-21 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ExcessStockSharesIssued Excess Stock, Shares Issued shares 4.73M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ExcessStockSharesOutstanding Excess Stock, Shares Outstanding shares 6.55M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD 1.26M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001213900-21-055498
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001213900-21-055498
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 2.39M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 33,833 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -11,207 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 5.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss Debt Securities, Held-to-maturity, Transfer to Trading, Unrealized Gain (Loss) USD -1,831 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -1.63M 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 1.92M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 233,792 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 489,335 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.29M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -481,484 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap IncreaseDecreaseInAccruedTaxesPayable Increase (Decrease) in Accrued Taxes Payable USD 24,345 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 1.66M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-06-22 0001213900-21-033574
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 58,615 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 30,941 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 93,193 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -109,436 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap IncreaseDecreaseInPrepaidInsurance Increase (Decrease) in Prepaid Insurance USD -94,936 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001213900-21-055498
us-gaap InterestAndDividendIncomeSecuritiesOther Interest and Dividend Income, Securities, Operating, Other USD 6,896 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap InterestExpense Interest Expense USD 41,759 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 233,996 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap InterestIncomeOther Interest Income, Other USD 6,896 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 222 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 25,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap LeaseCost Lease, Cost USD 122,291 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 881,855 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 93,052 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 382,583 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 406,220 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 135,071 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap Liabilities Liabilities USD 2.79M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 10.02M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 5.80M 2024-01-01 2024-06-30 2024 Q2 10-Q/A 2024-09-23 0000950170-24-108797
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 252,703 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap ManufacturingCosts Manufacturing Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap MarketableSecurities Marketable Securities USD 79,000 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 525,287 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -17,356 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -1,831 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 6.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -111,507 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -8.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -9.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -910,588 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-10-29 0001213900-21-055498
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -15.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest USD -2.13M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap NoninterestExpenseInvestmentAdvisoryFees Noninterest Expense Investment Advisory Fees USD 5.30M 2022-02-18 2023 FY 10-K/A 2024-09-23 0000950170-24-108793
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 490,369 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap NotesPayable Notes Payable USD 50,000 2021-10-13 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 774,345 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OperatingExpenses Operating Expenses USD 10.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -10.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OperatingLeaseCost Operating Lease, Cost USD 24,496 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 64,200 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034584
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 746,784 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 344,588 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 460,811 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 559,163 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 821,000 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.54M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 2,627 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 30,941 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 490,369 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 424,214 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap PartnersCapitalAccountContributions Partners' Capital Account, Contributions USD 750,000 2021-10-01 2021-10-13 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 35.50M 2022-01-10 2022 FY 10-K 2023-03-30 0000950170-23-011000
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 655,000 2022-02-18 2023 Q3 10-Q 2023-11-09 0000950170-23-062025
us-gaap PaymentsForRepurchaseOfRedeemablePreferredStock Payments for Repurchase of Redeemable Preferred Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034584
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 800,000 2024-02-05 2025 Q1 10-Q 2025-05-08 0000950170-25-066897
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 527,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 111,507 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap PaymentsToInvestInDecommissioningFund Payments to Acquire Investments to be Held in Decommissioning Trust Fund USD 482,871 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2023-12-31 2023 FY 10-K/A 2024-09-23 0000950170-24-108793
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 146,516 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 4,834 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap PrepaidInsurance Prepaid Insurance USD 206,270 2022-09-30 2022 Q3 10-Q 2022-11-10 0000950170-22-024436
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 2.50M 2022-01-01 2022-12-31 2023 FY 10-K/A 2024-09-23 0000950170-24-108793
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 5.40M 2024-02-05 2025 Q1 10-Q 2025-05-08 0000950170-25-066897
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 12.60M 2024-01-01 2024-12-31 2025 Q3 10-Q 2025-11-06 0001193125-25-269450
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.23M 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 6.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 750,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ProceedsFromPreviousAcquisition Proceeds from Previous Acquisition USD 11.90M 2022-01-10 2023 FY 10-K/A 2024-09-23 0000950170-24-108793
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 150,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ProceedsFromRepaymentsOfDebt Proceeds from (Repayments of) Debt USD 25,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 140,000 2020-01-01 2020-09-30 2021 Q3 10-Q 2021-10-29 0001213900-21-055498
us-gaap ProceedsFromRepaymentsOfRelatedPartyDebt Proceeds from (Repayments of) Related Party Debt USD 140,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 525,287 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 6.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap ProfessionalFees Professional Fees USD 315,846 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.13M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 286,536 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 163,847 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 150,000 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-06-16 0001213900-21-032736
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K/A 2024-09-23 0000950170-24-108793
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 150,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 125,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -59.07M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 740,918 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 6.29M 2020-01-01 2020-12-31 2022 Q3 10-Q 2022-11-10 0000950170-22-024436
us-gaap SecurityDepositLiability Security Deposit Liability USD 6,000 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.106 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.013 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap SharePrice Share Price USD/shares 11.5 2020-10-13 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap SharesIssued Shares, Issued shares 99,449 2022-01-10 2022 FY 10-K 2023-03-30 0000950170-23-011000
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.6 2022-07-28 2022 Q3 10-Q 2022-11-10 0000950170-22-024436
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares shares 2.54M 2021-10-27 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 64,200 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 7.23M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -7.82M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.25 2026-01-28 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap StockIssued1 Stock Issued USD 114 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 166,405 2024-01-01 2024-12-31 2025 Q3 10-Q 2025-11-06 0001193125-25-269450
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 85,311 2024-02-05 2025 Q1 10-Q 2025-05-08 0000950170-25-066897
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 25,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 99,998 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-011000
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 25,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap StockOptionExercisePriceIncrease Stock Option, Exercise Price, Increase USD/shares 357.1 2022-01-10 2022 FY 10-K 2023-03-30 0000950170-23-011000
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD -5.41M 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 6,896 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap TemporaryEquityAggregateAmountOfRedemptionRequirement Temporary Equity, Aggregate Amount of Redemption Requirement USD 750,000 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 47.81M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 4.73M 2021-12-31 2021 FY 10-K 2022-04-15 0001213900-22-020179
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 2.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap VariableLeaseCost Variable Lease, Cost USD 33,595 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001193125-26-076552
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 522,028 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 14.20M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-009906
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 522,028 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001193125-26-450194

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →